0.00Open0.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover0.00%IV-47.37%PremiumDec 20, 2024Expiry Date1.80Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.34Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Altus Power Stock Discussion
Altus Power Strengthens its Presence in Maine with Operationalization of Three New Community Solar Projects
Seems like a good dip to get in
NEWS
Amprius Wins Inaugural CleanTech Breakthrough Battery Technology Company of the Year Award
Amprius Technologies, Inc. (NYSE: AMPX) wins CleanTech Breakthrough Battery Technology Company of the Year award. The company's high-energy density batteries are gaining recognition in the industry. Dr. Kang Sun, CEO, highlights the company's dedication to innovation and growth in the electric mobility sector.
In reaction to earnings/guidance:
• $Vail Resorts (MTN.US)$ +3.7%, $The Duckhorn Portfolio (NAPA.US)$ +2.7%, $Jefferies Financial (JEF.US)$ +1.6%
Other news:
• $Axsome Therapeutics (AXSM.US)$ +4.3% (disclosesplansto resubmit AXS-07 NDA basedonsuccessfulFDAtype a meeting)
• $Invivyd (IVVD.US)$ +4.1% (files for $400mlnmixed securities shelf offering)
• $Tritium DCFC (DCFC.US)$ +3.1%(tosupply fast chargers for Australia's l...
$Acumen Pharmaceuticals (ABOS.US)$ $Altus Power (AMPS.US)$ $Abasca Resources Inc (AMV.CA)$ $Coupang (CPNG.US)$ $Disney (DIS.US)$ $Klx Energy Services (KLXE.US)$ $Mind Medicine (MNMD.US)$ $PepGen (PEPG.US)$ $SOBR Safe (SOBR.US)$ $Top Ships (TOPS.US)$ $Windtree Therapeutics (WINT.US)$
ON THE WATCH: $13.05
FIRST SIGNED OF MORE UPTREND: $13.15
NEED IT TO BREAK OVER: $13.24
key indicator for MORE uptrend $13.46
confirmation uptrend - $13.69
mini breakout - $13.97. $Altus Power (AMPS.US)$
- Alpha Tau Announces Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site, Amended Radioactive License with Increased Capacity at Lawrence, MA Site
$Day One Biopharmaceuticals (DAWN.US)$
- Co on Sunday Announced Results of Relapsed Pediatric Low-Grade Glioma Show 64% Overall Response Rate next resistance at $20
$Comera Life Sciences (CMRA.US)$
- Comera Life Sciences shares are trading higher...
No comment yet